Studies have confirmed that CD248 was overexpressed in CAFs of hepatocellular carcinoma (HCC), which promoted the polarization of tumor-associated macrophages (TAMs) to the M2 phenotype, an inhibitory maker in TME, by regulating growth arrest-specific protein 6 (GAS6) (19). Here, CD248 is linked to hepatocellular carcinoma.